undefined
EUTM file information

018312977

BIJUVE

September 24, 2020

Trademark Summary

The trademark application BIJUVE was filed by TherapeuticsMD, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 5, 2020, and it was registered by office on February 12, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Goods And Services

  • The mark was filed in class 5 with Hormone replacement therapy preparations, namely, capsules containing estradiol and progesterone for use in treating the symptoms associated with menopause.